Add to ORKGThe effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 tria
Objective: The purpose of this investigation was to determine whether an association exists between ...
Body mass index (BMI) is a main indicator of obesity and its association with breast cancer is well ...
Introduction Obese breast cancer patients have worse prognosis than normal weight patients, but t...
BACKGROUND: Obesity has been shown to be an indicator of poor prognosis for patients with primary br...
International audienceBackground: Obesity has been shown to be an indicator of poor prognosis for pa...
PURPOSE Lipophilic drugs, such as taxanes, have a high affinity for adipose tissue and a resulting h...
PURPOSE: Lipophilic drugs, such as taxanes, have a high affinity for adipose tissue and a resulting ...
Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed t...
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and tax...
The evidence emerged from the TOURANDOT trial encourages evaluating the role of anthropometric deter...
The prevalence of obesity is rising worldwide including Sub-Saharan Africa just as the incidence of ...
Background: The effect of body mass index (BMI) on the prognosis of metastatic breast cancer (MBC) h...
BACKGROUND: Obesity has been associated with an adverse prognosis and reduced efficacy of endocrine ...
Purpose: The effects of body mass index on pathologic complete response and survival have not been r...
The prognostic value of Body Mass Index (BMI) on breast cancer outcome is controversial and previous...
Objective: The purpose of this investigation was to determine whether an association exists between ...
Body mass index (BMI) is a main indicator of obesity and its association with breast cancer is well ...
Introduction Obese breast cancer patients have worse prognosis than normal weight patients, but t...
BACKGROUND: Obesity has been shown to be an indicator of poor prognosis for patients with primary br...
International audienceBackground: Obesity has been shown to be an indicator of poor prognosis for pa...
PURPOSE Lipophilic drugs, such as taxanes, have a high affinity for adipose tissue and a resulting h...
PURPOSE: Lipophilic drugs, such as taxanes, have a high affinity for adipose tissue and a resulting ...
Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed t...
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and tax...
The evidence emerged from the TOURANDOT trial encourages evaluating the role of anthropometric deter...
The prevalence of obesity is rising worldwide including Sub-Saharan Africa just as the incidence of ...
Background: The effect of body mass index (BMI) on the prognosis of metastatic breast cancer (MBC) h...
BACKGROUND: Obesity has been associated with an adverse prognosis and reduced efficacy of endocrine ...
Purpose: The effects of body mass index on pathologic complete response and survival have not been r...
The prognostic value of Body Mass Index (BMI) on breast cancer outcome is controversial and previous...
Objective: The purpose of this investigation was to determine whether an association exists between ...
Body mass index (BMI) is a main indicator of obesity and its association with breast cancer is well ...
Introduction Obese breast cancer patients have worse prognosis than normal weight patients, but t...